Search research articles
Contact Us
Filters
Showing results (61-70 of 118) with videos related to
Page
of 12
Sort By:
Nature Immunology
|
March 29, 2011
CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions
Amir Schajnovitz, Tomer Itkin, Gabriele D'Uva, et al.
Leukemia & Lymphoma
|
May 7, 2015
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study
Anat Gafter-Gvili, Elena Ribakovsky, Nadav Mizrahi, et al.
JACC. Cardiooncology
|
January 13, 2025
Atherosclerotic Cardiovascular Diseases Are Associated With Incident Metastatic and Nonmetastatic Cancer
Tal Caller, Alexander Fardman, Yariv Gerber, et al.
Hematological Oncology
|
November 2, 2019
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study
Shai Shimony, Netanel Horowitz, Elena Ribakovsky, et al.
Acta Haematologica
|
March 12, 2024
Efficacy of Preexposure Prophylaxis with Monoclonal Antibody Tixagevimab-Cilgavimab against Emerging SARS-CoV-2 Resistant Variants in Patients with Chronic Lymphocytic Leukemia
Ohad Benjamini, Tamar Tadmor, Abraham Avigdor, et al.
Oncotarget
|
June 25, 2020
Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia
Jonathan Canaani, Meital Nagar, Gabriel Heering, et al.
Bone Marrow Transplantation
|
December 3, 2020
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphoma
Ivetta Danylesko, Roni Shouval, Noga Shem-Tov, et al.
Expert Review of Anticancer Therapy
|
July 1, 2024
First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC
Pierre Peterlin, Esma Saada-Bouzid, Mor Moskovitz, et al.
European Journal of Haematology
|
October 8, 2022
Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL
Ohad Benjamini, Rotem Gershon, Erez Bar-Haim, et al.
Leukemia & Lymphoma
|
August 11, 2023
Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma
Shalev Fried, Eden Shkury, Orit Itzhaki, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 118) with videos related to
Sort By:
Page
of 12
Nature Immunology
|
March 29, 2011
CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions
Amir Schajnovitz, Tomer Itkin, Gabriele D'Uva, et al.
Leukemia & Lymphoma
|
May 7, 2015
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study
Anat Gafter-Gvili, Elena Ribakovsky, Nadav Mizrahi, et al.
JACC. Cardiooncology
|
January 13, 2025
Atherosclerotic Cardiovascular Diseases Are Associated With Incident Metastatic and Nonmetastatic Cancer
Tal Caller, Alexander Fardman, Yariv Gerber, et al.
Hematological Oncology
|
November 2, 2019
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study
Shai Shimony, Netanel Horowitz, Elena Ribakovsky, et al.
Acta Haematologica
|
March 12, 2024
Efficacy of Preexposure Prophylaxis with Monoclonal Antibody Tixagevimab-Cilgavimab against Emerging SARS-CoV-2 Resistant Variants in Patients with Chronic Lymphocytic Leukemia
Ohad Benjamini, Tamar Tadmor, Abraham Avigdor, et al.
Oncotarget
|
June 25, 2020
Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia
Jonathan Canaani, Meital Nagar, Gabriel Heering, et al.
Bone Marrow Transplantation
|
December 3, 2020
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphoma
Ivetta Danylesko, Roni Shouval, Noga Shem-Tov, et al.
Expert Review of Anticancer Therapy
|
July 1, 2024
First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC
Pierre Peterlin, Esma Saada-Bouzid, Mor Moskovitz, et al.
European Journal of Haematology
|
October 8, 2022
Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL
Ohad Benjamini, Rotem Gershon, Erez Bar-Haim, et al.
Leukemia & Lymphoma
|
August 11, 2023
Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma
Shalev Fried, Eden Shkury, Orit Itzhaki, et al.
Page
of 12